Literature DB >> 10975814

The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.

I Gramaglia1, A Jember, S D Pippig, A D Weinberg, N Killeen, M Croft.   

Abstract

The costimulatory receptor OX40 has recently been shown to be involved in primary CD4 responses to several defined Ags. However, to date there has been little information regarding the mechanism of action of OX40, such as whether it regulates T cell numbers, reactivity, or both, and whether it contributes to induction of long-term T cell responses. With an agonist Ab to OX40, and by tracking Ag-specific TCR transgenic T cells in vivo, we show that ligation of OX40 induces clonal expansion and survival of CD4 cells during primary responses, and results in the accumulation of greater numbers of memory cells with time. Significantly, OX40-deficient T cells, from mice generated by gene targeting, secrete IL-2 and proliferate normally during the initial period of activation, but cannot sustain this during the latter phases of the primary response, exhibiting decreased survival over time. Mice lacking OX40 develop only low frequencies of Ag-specific CD4 cells late in primary responses in vivo and generate dramatically lower frequencies of surviving memory cells. These results demonstrate that OX40-OX40L interactions control primary T cell expansion and the ability to retain high numbers of Ag-specific T cells. In this way, OX40 signals promote survival of greater numbers of T cells with time and control the size of the memory T cell pool.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975814     DOI: 10.4049/jimmunol.165.6.3043

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  121 in total

1.  Human vascular smooth muscle cells lack essential costimulatory molecules to activate allogeneic memory T cells.

Authors:  Pei Zhang; Thomas D Manes; Jordan S Pober; George Tellides
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06-10       Impact factor: 8.311

2.  CARMA1 is necessary for optimal T cell responses in a murine model of allergic asthma.

Authors:  Ravisankar A Ramadas; Marly I Roche; James J Moon; Thomas Ludwig; Ramnik J Xavier; Benjamin D Medoff
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

3.  A caspase 8-based suicide switch induces apoptosis in nanobody-directed chimeric receptor expressing T cells.

Authors:  Sepideh Khaleghi; Fatemeh Rahbarizadeh; Davoud Ahmadvand; Mohammad J Rasaee; Philippe Pognonec
Journal:  Int J Hematol       Date:  2012-03-11       Impact factor: 2.490

4.  Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations.

Authors:  Hiroshi Kato; Hidefumi Kojima; Naoto Ishii; Hidenori Hase; Yutaka Imai; Takashi Fujibayashi; Kazuo Sugamura; Testuji Kobata
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

Review 5.  Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut?

Authors:  Zili Zhang; James T Rosenbaum; Wenwei Zhong; Carmen Lim; David J Hinrichs
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

6.  Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-β.

Authors:  Yuan Zhao; Yan Fei Adams; Michael Croft
Journal:  Viral Immunol       Date:  2011-09-29       Impact factor: 2.257

7.  Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts.

Authors:  Cheguevara Afaneh; Thangamani Muthukumar; Michelle Lubetzky; Ruchuang Ding; Catherine Snopkowski; Vijay K Sharma; Surya Seshan; Darshana Dadhania; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

Review 8.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

9.  Anaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in mice.

Authors:  Judith T Murphy; Andre P Burey; Amy M Beebe; Danling Gu; Leonard G Presta; Taha Merghoub; Jedd D Wolchok
Journal:  Blood       Date:  2014-02-20       Impact factor: 22.113

10.  Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization.

Authors:  Yi T Koh; Andrew Gray; Sean A Higgins; Bolyn Hubby; W Martin Kast
Journal:  Prostate       Date:  2009-05-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.